Skip to main content
Equibles

Alphabet Inc.

Position in LYEL — Lyell Immunopharma, Inc.

CIK 1652044 Mountain View, CA
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$4,120,246
-$1,762,469 QoQ
Shares Held
293,256
0.0% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 87 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Alphabet Inc. holds $884,358,161 across 13 Biotechnology names. LYEL ranks #11 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,946,619 $551,842,806
2 PBLS
Parabilis Medicines, Inc.
 4,919,498 $134,646,660
3 PRME
Prime Medicine, Inc.
 16,562,498 $61,115,617
4 MAZE
Maze Therapeutics, Inc.
 1,388,583 $41,435,316
5 RLAY
Relay Therapeutics, Inc.
 1,410,029 $26,381,642
6 BBOT
BridgeBio Oncology Therapeutics, Inc.
 2,823,126 $21,512,220
7 BEAM
Beam Therapeutics Inc.
 321,604 $11,037,449
8 VERA
Vera Therapeutics, Inc.
 241,264 $10,352,638

All Filings in LYEL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,120,246 293,256
2026-03-31 $5,882,715 293,256
2025-12-31 $9,026,419 293,256
2025-09-30 $4,762,477 293,256
2025-06-30 $2,592,383 293,256
2025-03-31 $3,155,437 5,865,125
2024-12-31 $3,753,680 5,865,125
2024-09-30 $8,093,872 5,865,125
2024-06-30 $8,504,431 5,865,125
2024-03-31 $13,079,228 5,865,125
2023-12-31 $11,378,342 5,865,125
2023-09-30 $8,621,733 5,865,125
2023-06-30 $18,651,097 5,865,125
2023-03-31 $13,841,695 5,865,125
2022-12-31 $20,351,983 5,865,125
2022-09-30 $42,991,366 5,865,125
2022-06-30 $38,240,615 5,865,125
2022-03-31 $29,618,881 5,865,125
2021-12-31 $45,396,067 5,865,125
2021-09-30 $86,803,850 5,865,125
2021-06-30 $95,249,630 5,865,125